McMurray JJ
37  Ergebnisse:
Personensuche X
?
 
?
5

Does Atrial Fibrillation Affect Outcomes in Patients Admitt..:

Abualnaja, S ; Podder, M ; Hernandez, AF...
Canadian Journal of Cardiology.  29 (2013)  10 - p. S147-S148 , 2013
 
?
6

Dapagliflozin and new-onset type 2 diabetes in patients wit..:

Rossing, P ; Inzucchi, SE ; Vart, P...
https://discovery.ucl.ac.uk/id/eprint/10140959/1/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20T2D_LDE_revised_clean.pdf.  , 2022
 
?
7

The genomics of heart failure: design and rationale of the ..:

Lumbers, RT ; Shah, S ; Lin, H...
https://discovery.ucl.ac.uk/id/eprint/10134393/17/Lumbers_The%20genomics%20of%20heart%20failure-%20design%20and%20rationale%20of%20the%20HERMES%20consortium_AOP.pdf.  , 2021
 
?
8

A pre-specified analysis of the Dapagliflozin and Preventio..:

Heerspink, HJ ; Cherney, D ; Postmus, D...
https://discovery.ucl.ac.uk/id/eprint/10135687/1/1-s2.0-S0085253821008656-main.pdf.  , 2021
 
?
9

Daprodustat for the Treatment of Anemia in Patients Not Und..:

Singh, AK ; Carroll, K ; McMurray, JJ...
https://discovery.ucl.ac.uk/id/eprint/10138633/1/nejmoa2113380.pdf.  , 2021
 
?
10

Daprodustat for the Treatment of Anemia in Patients Undergo..:

Singh, AK ; Carroll, K ; Perkovic, V...
https://discovery.ucl.ac.uk/id/eprint/10138634/1/nejmoa2113379.pdf.  , 2021
 
?
11

Effects of dapagliflozin on major adverse kidney and cardio..:

Wheeler, DC ; Stefansson, B ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10122004/1/Wheeler_DAPA-CKD_Diabetes_and_CKD_aetiology_Revd_Ms_Clean_REVISED15OCT.pdf.  , 2021
 
?
12

NT-proBNP by Itself Predicts Death and Cardiovascular Event..:

Malachias, MVB ; Jhund, PS ; Claggett, BL...
https://discovery.ucl.ac.uk/id/eprint/10123766/1/JAHA.120.017462.pdf.  , 2020
 
?
14

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predic..:

Idzerda, NMA ; Persson, F ; Pena, MJ...
https://discovery.ucl.ac.uk/id/eprint/10053848/13/Chaturvedi%20VoR%20Idzerda_et_al-2018-Diabetes,_Obesity_and_Metabolism.pdf.  , 2018
 
1-15